Filing Details

Accession Number:
0001209191-23-025930
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-28 06:00:11
Reporting Period:
2023-04-26
Accepted Time:
2023-04-28 06:00:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1394319 Tracon Pharmaceuticals Inc. TCON Biological Products, (No Disgnostic Substances) (2836) 342037594
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1631338 Charles Theuer C/O Tracon Pharmaceuticals, Inc.
4350 La Jolla Village Drive, Suite 800
San Diego CA 92122
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-26 3,999 $0.66 352,417 No 4 P Direct
Common Stock Acquisiton 2023-04-27 47,000 $0.75 399,417 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes 3,500 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2023.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.72 to $0.7596, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.